Håkan Wickholm

Håkan Wickholm has a diverse work experience spanning several companies and roles. Håkan started their career at AstraZeneca, where they held various positions in sales and marketing from 1988 to 1999. Håkan then went on to become the Managing Director of Astra-Synthelabo from 1997 to 2000, followed by the General Manager of Gulf States from 2000 to 2003. Wickholm later served as the Vice President of Mature Brands and Local Products from 2003 to 2009, and as the Regional Business Development Director for CEEMEA (C and E Europe / Russia and CIS/ Middle East, Africa) from 2009 to 2012.

In 2013, Wickholm joined PledPharma AB as the Business Development Director until 2014. Håkan also founded GHW Consulting AB in 2013. Wickholm then held various positions at Lytix Biopharma, including Head of Business Development / Chief Business Officer from 2014 to 2016, Chief Executive Officer (Interim) from 2016 to 2017, and Chief Business Officer from 2017 to 2018.

More recently, Wickholm has served as a Board Director at Beactica Therapeutics since November 2018 and at Genovis since May 2019.

Håkan Wickholm obtained their Bachelor of Business Administration degree with a specialization in International Business from Uppsala University, where they studied from 1984 to 1988. Håkan then pursued further education at the University of Warwick - Warwick Business School, where they obtained a Postgraduate Diploma in General Management and Finance. However, the specific dates for this diploma program are not mentioned.